StemCells, Inc. Presents Interim Results from its Phase II Pathway Study in Chronic Cervical Spinal Cord Injury at ASIA Annual Meeting Biotech Investing
Mersana Therapeutics’ New Immunoconjugate Demonstrates Anti-Cancer Activity in Non-Small Cell Lung Cancer and Ovarian Cancer Tumor Models Biotech Investing
INNATE PHARMA: New preclinical data further supporting the development of IPH4301 presented at the AACR meeting Biotech Investing
Thetis Pharmaceuticals to Present at the World Orphan Drug Congress on TP-252, an Investigational Drug for Familial Adenomatous Polyposis Biotech Investing
New Analyses of the Phase 3 POISE Trial of Ocaliva™ (Obeticholic Acid) for the Treatment of PBC Presented at EASL Biotech Investing
Naturally Splendid Revises 2016 First Quarter Gross Sales Figures and Attends International Tradeshow in Singapore Biotech Investing
Orgenesis Approved for Additional European Grant for Further Development of its Type 1 Diabetes Program Biotech Investing
TG Therapeutics, Inc. Announces Issuance of Composition of Matter Patent for TG-1101 in the United States Biotech Investing
vTv Therapeutics Announces Presentations on its Diabetes Product Candidates TTP273 and TTP399 at the Keystone Symposia on New Therapeutics for Diabetes and Obesity Biotech Investing
